Benefits and Risks to Mother and Infant of Drug Treatment for Postnatal Depression

ISSN： 0114-5916

Source： Drug Safety, Vol.25, Iss.13, 2002-01, pp. : 903-911

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risks and Benefits of Selective Serotonin Reuptake Inhibitors in the Treatment of Depression

By Mourilhe P. Stokes P.E.

Drug Safety, Vol. 18, Iss. 1, 1998-01 ,pp. : 57-82

Adis International

Access to resources Recommend Favorite

Fluoxetine – do the benefits outweigh the risks in adolescent major depression?

By Doggrell Sheila A

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 1, 2005-01 ,pp. : 147-150

Informa Healthcare

Access to resources Recommend Favorite

THERAPISTS’ EXPERIENCES OF MOTHER–INFANT PSYCHOANALYTIC TREATMENT: A QUALITATIVE STUDY

Infant Mental Health Journal, Vol. 39, Iss. 1, 2018-01 ,pp. : 55-69

John Wiley & Sons Inc

Access to resources Recommend Favorite

Drug Therapy for Acute Ischaemic Stroke: Risks versus Benefits

By Lindley R.I.

Drug Safety, Vol. 19, Iss. 5, 1998-11 ,pp. : 373-382

Adis International

Access to resources Recommend Favorite

Hypertriglyceridemia: Associated Risks and Effect of Drug Treatment

By Jonkers I.J.A.M.

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 6, 2001-06 ,pp. : 455-466

Adis International

Access to resources Recommend Favorite